112 related articles for article (PubMed ID: 1319617)
41. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes.
Cook JJ; Niewiarowski S; Yan Z; Schaffer L; Lu W; Stewart GJ; Mosser DM; Myers JA; Maione TE
Circulation; 1992 Mar; 85(3):1102-9. PubMed ID: 1537108
[TBL] [Abstract][Full Text] [Related]
42. Further characterization of the interaction of histidine-rich glycoprotein with heparin: evidence for the binding of two molecules of histidine-rich glycoprotein by high molecular weight heparin and for the involvement of histidine residues in heparin binding.
Burch MK; Blackburn MN; Morgan WT
Biochemistry; 1987 Nov; 26(23):7477-82. PubMed ID: 3427089
[TBL] [Abstract][Full Text] [Related]
43. The heparin binding site of protein C inhibitor is protease-dependent.
Li W; Huntington JA
J Biol Chem; 2008 Dec; 283(51):36039-45. PubMed ID: 18974053
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.
España F; Hendl S; Gilabert J; Estellés A; Aznar J
Thromb Res; 1993 Jun; 70(5):375-84. PubMed ID: 8397450
[TBL] [Abstract][Full Text] [Related]
45. The antiheparin effect of alpha1-acid glycoprotein and platelet material, evaluated by the heparin thrombin clotting time.
Andersen P; Godal HC
Haemostasis; 1977; 6(6):339-46. PubMed ID: 611047
[TBL] [Abstract][Full Text] [Related]
46. Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin.
Kassaar O; Schwarz-Linek U; Blindauer CA; Stewart AJ
J Thromb Haemost; 2015 Jan; 13(1):101-10. PubMed ID: 25353308
[TBL] [Abstract][Full Text] [Related]
47. A new and simple isolation procedure for human protein C inhibitor. Evidence for a second inhibitor for activated protein C present in human plasma.
Radtke KP; Stief TW; Heimburger N
Biol Chem Hoppe Seyler; 1988 Sep; 369(9):965-74. PubMed ID: 2852498
[TBL] [Abstract][Full Text] [Related]
48. Platelet factor 4 enhances generation of activated protein C in vitro and in vivo.
Slungaard A; Fernandez JA; Griffin JH; Key NS; Long JR; Piegors DJ; Lentz SR
Blood; 2003 Jul; 102(1):146-51. PubMed ID: 12609838
[TBL] [Abstract][Full Text] [Related]
49. Plasma fatty acid levels may regulate the Zn(2+)-dependent activities of histidine-rich glycoprotein.
Stewart AJ; Blindauer CA; Sadler PJ
Biochimie; 2009; 91(11-12):1518-22. PubMed ID: 19679159
[TBL] [Abstract][Full Text] [Related]
50. Divalent metal binding by histidine-rich glycoprotein differentially regulates higher order oligomerisation and proteolytic processing.
Priebatsch KM; Poon IK; Patel KK; Kvansakul M; Hulett MD
FEBS Lett; 2017 Jan; 591(1):164-176. PubMed ID: 27930811
[TBL] [Abstract][Full Text] [Related]
51. Proteolysis of histidine-rich glycoprotein in plasma and in patients undergoing thrombolytic therapy.
Smith A; Nuiry I; Morgan WT
Thromb Res; 1985 Dec; 40(5):653-61. PubMed ID: 2935971
[TBL] [Abstract][Full Text] [Related]
52. Platelet factor 4 modulation of the thrombomodulin-protein C system.
Slungaard A
Crit Care Med; 2004 May; 32(5 Suppl):S331-5. PubMed ID: 15118540
[TBL] [Abstract][Full Text] [Related]
53. Human histidine-rich glycoprotein expressed in SF9 insect cells inhibits apatite formation.
Schinke T; Koide T; Jahnen-Dechent W
FEBS Lett; 1997 Aug; 412(3):559-62. PubMed ID: 9276466
[TBL] [Abstract][Full Text] [Related]
54. Protease-induced immunoregulatory activity of platelet factor 4.
Katz IR; Thorbecke GJ; Bell MK; Yin JZ; Clarke D; Zucker MB
Proc Natl Acad Sci U S A; 1986 May; 83(10):3491-5. PubMed ID: 3517862
[TBL] [Abstract][Full Text] [Related]
55. Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems.
Blank M; Shoenfeld Y
Clin Rev Allergy Immunol; 2008 Jun; 34(3):307-12. PubMed ID: 18219588
[TBL] [Abstract][Full Text] [Related]
56. Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma.
Lijnen HR; Hoylaerts M; Collen D
J Biol Chem; 1983 Mar; 258(6):3803-8. PubMed ID: 6833231
[TBL] [Abstract][Full Text] [Related]
57. Functional Regulation of the Plasma Protein Histidine-Rich Glycoprotein by Zn
Priebatsch KM; Kvansakul M; Poon IK; Hulett MD
Biomolecules; 2017 Mar; 7(1):. PubMed ID: 28257077
[TBL] [Abstract][Full Text] [Related]
58. Platelet factor 4: an inhibitor of collagenase.
Hiti-Harper J; Wohl H; Harper E
Science; 1978 Mar; 199(4332):991-2. PubMed ID: 203038
[TBL] [Abstract][Full Text] [Related]
59. Identification of monoclonal antibodies that inhibit the function of protein C inhibitor. Evidence for heparin-independent inhibition of activated protein C in plasma.
Meijers JC; Vlooswijk RA; Kanters DH; Hessing M; Bouma BN
Blood; 1988 Oct; 72(4):1401-3. PubMed ID: 2844328
[TBL] [Abstract][Full Text] [Related]
60. Enhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoprotein.
Ringvall M; Thulin Å; Zhang L; Cedervall J; Tsuchida-Straeten N; Jahnen-Dechent W; Siegbahn A; Olsson AK
PLoS One; 2011 Jan; 6(1):e14526. PubMed ID: 21264222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
